Trial Profile

Phase 2b/3 pivotal study in Primary Mitochondrial Diseases patients with myopathy and/or cardiomyopathy

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 12 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Feb 2026 New trial record
29 Jan 2026 According to an OMEICOS Therapeutics Media Release, trial results support transition into Late-Stage Development with program expected to be phase 2b/3-ready in H2 2026.
29 Jan 2026 According to an OMEICOS Therapeutics media release, s preparing for a potentially pivotal Phase 2b/3 study in PMD patients with myopathy and/or cardiomyopathy across EU and US sites and expects to be ready to initiate this study later this year. subject to the completion of partnering discussions.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com